From the "pot-bellied" appearance to the flaws in the LDDST, Cushing's disease remains one of our most complex endocrine ...
TipRanks on MSN
Crinetics Pharma’s Promising Study on CRN04894 for Cushing’s Syndrome: A Potential Game-Changer?
Crinetics Pharma (($CRNX)) announced an update on their ongoing clinical study. Crinetics Pharmaceuticals is conducting a study titled ‘A Phase ...
Expert Rev Endocrinol Metab. 2013;8(2):183-193. Mitotane reduces cortisol synthesis through the inhibition of 11B-hydroxylase, 18-hydroxylase, 3-α hydroxylase, hydroxysteroid dehydrogenase and several ...
Background: Cushing's disease is very rare in the paediatric population. Although uncommon, corticotroph hyperplasia causing Cushing's syndrome has been described in the adult population, but appears ...
On Thursday, Corcept Therapeutics Incorporated (NASDAQ:CORT) said that the primary endpoint was met in the treatment phase of CATALYST, a randomized, double-blind, placebo-controlled study of Korlym ...
LUBBOCK, Texas (KCBD) - Victoria and Marcus Lucio met each other in 2016 while attending Texas Tech University. They have two children, five-year-old Roman and two-year-old Kairo. They love to go to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback